Advertisement

Index by author

May 01, 1993; Volume 265,Issue 2

  1. Wallace, A A

    1. Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agent.
      J J Lynch, A A Wallace, L H Van der Gaag, E P Baskin, C M Bear, J R Gehret, T Kothstein, R F Stupienski, S D Appleby and M C Sanguinetti
      Journal of Pharmacology and Experimental Therapeutics May 1993, 265 (2) 720-730;

  2. Walton, M I

    1. Pharmacokinetics and bioreductive metabolism of the novel benzotriazine di-N-oxide hypoxic cell cytotoxin tirapazamine (WIN 59075; SR 4233; NSC 130181) in mice.
      M I Walton and P Workman
      Journal of Pharmacology and Experimental Therapeutics May 1993, 265 (2) 938-947;

  3. Waxman, D J

    1. Irreversible suppression of growth hormone-dependent cytochrome P450 2C11 in adult rats neonatally treated with monosodium glutamate.
      B H Shapiro, N A Pampori, P A Ram and D J Waxman
      Journal of Pharmacology and Experimental Therapeutics May 1993, 265 (2) 979-984;

  4. Weber, S J

    1. Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.
      P J Horan, K D Wild, A Misicka, A Lipkowski, R C Haaseth, V J Hruby, S J Weber, T P Davis, H I Yamamura and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1993, 265 (2) 896-902;

  5. Wegner, C D

    1. A prodrug of a 2,6-disubstituted 4-(2-arylethenyl)phenol is a selective and orally active 5-lipoxygenase inhibitor.
      P R Farina, A G Graham, C A Homon, E S Lazer, S E Hattox, P S Riska, R H Gundel and C D Wegner
      Journal of Pharmacology and Experimental Therapeutics May 1993, 265 (2) 483-489;

  6. Wei, E T

    1. Xenopsin, neurotensin, neurotensin(8-13) and N-acetyl-neurotensin(8-13) inhibit vascular leakage in rats after tissue injury.
      G C Gao and E T Wei
      Journal of Pharmacology and Experimental Therapeutics May 1993, 265 (2) 619-625;

  7. Welch, S P

    1. Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice.
      S P Welch
      Journal of Pharmacology and Experimental Therapeutics May 1993, 265 (2) 633-640;

  8. White, F J

    1. Electrophysiological effects of putative autoreceptor-selective dopamine agonists on A10 dopamine neurons.
      J M Ackerman, P A Johansen, D Clark and F J White
      Journal of Pharmacology and Experimental Therapeutics May 1993, 265 (2) 963-970;

  9. Wientjes, M G

    1. Gastrointestinal and hepatic first-pass elimination of 2',3'-dideoxyinosine in rats.
      S L Bramer, J L Au and M G Wientjes
      Journal of Pharmacology and Experimental Therapeutics May 1993, 265 (2) 731-738;

  10. Wild, K D

    1. Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.
      P J Horan, K D Wild, A Misicka, A Lipkowski, R C Haaseth, V J Hruby, S J Weber, T P Davis, H I Yamamura and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1993, 265 (2) 896-902;
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue

Advertisement